Atricure Inc. buy UBS Group AG
Start price
30.04.25
/
50%
€29.29
Target price
30.04.26
€51.01
Performance (%)
22.23%
Price
15.12.25
€35.80
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG currently has a performance of 22.23%. This prediction currently runs until 30.04.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Atricure Inc. | 2.959% | 2.959% |
| iShares Core DAX® | 0.795% | 1.458% |
| iShares Nasdaq 100 | -3.088% | -0.762% |
| iShares Nikkei 225® | -0.952% | -2.268% |
| iShares S&P 500 | -1.393% | 0.199% |
Comments by UBS_Group_AG for this prediction
In the thread Atricure Inc. diskutieren
AtriCure, Inc. (NASDAQ: ATRC) had its price target lowered by analysts at UBS Group AG from $60.00 to $58.00. They now have a "buy" rating on the stock.
Ratings data for ATRC provided by MarketBeat